EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Identification of CD320-Associated Cobalamin Transport Deficiency Through Newborn Screening Caused by Novel Homozygous Candidate Variants

Faisal Almalki iD, Amal Saleh Alsofyany, Abdulaziz K Almalki, Ashraf Oudah Abu Shuaylan, Haya Alruqi iD, Jwaher Mesleh Althobiti

Genes · 2026

DOI: 10.3390/genes17091108 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Genes, 2026. Verfasst von Faisal Almalki und 5 weiteren Autor:innen. Beteiligte Einrichtung: Clinical Laboratory Sciences, Applied Medical Science, Taibah University, Medina 42353, Saudi Arabia. Hauptthemen laut MEDLINE: Receptors, Cell Surface, Vitamin B 12 Deficiency. Die Arbeit nennt 21 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Research, Development and Innovation Authority, Research, Development and Innovation Authority, Kingdom of Saudi Arabia.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

The transcobalamin receptor, encoded by the CD320 gene, mediates the cellular uptake of the transcobalamin–cobalamin complex (vitamin B12). Pathogenic variants in CD320 impair the intracellular transport, resulting in methylmalonic acid (MMA) and propionylcarnitine (C3) level, despite normal circulating vitamin B12 levels, with variable clinical phenotypes.

Methods

Whole-exome sequencing (WES) was carried out for a newborn screening positive proband. Further plasma metabolic investigation and blood gas analysis were carried out for the proband. Sanger sequencing was carried out to confirm the candidate variant and identify the familial segregation.

Results

The proband presented with elevated C3 and MMA levels and exhibited an expanded clinical phenotype that included severe microcephaly, metabolic acidosis, low bicarbonate and pancytopenia. WES identified a homozygous missense candidate variant in the last amino acid of exon 1 in the CD320 gene (NM_016579.3: c.142G>C, p.Gly48Arg). Another adjacent synonymous homozygous candidate variant was identified (NM_016579.3: c.141A>C, p.Ala47=). Both variants were identified in a male proband from a consanguineous family. Both variants were confirmed by Sanger and segregated within the family members. During one year of follow-up, the patient showed persistent microcephaly while receiving a specialized metabolic formula and levocarnitine supplementation.

Conclusions

This study identified a novel recessive missense candidate variant and an adjacent synonymous candidate variant in CD320, supported with biochemical and clinical features of CD320-associated cobalamin transport deficiency. This suggests microcephaly may be a previously unrecognized phenotype with possible association of impaired intracellular cobalamin transport, while elevated C3 detected through routine newborn screening may be the earliest biochemical indicator of CD320-associated cobalamin transport deficiency.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Receptors, Cell SurfaceVitamin B 12 DeficiencyFemaleHumansInfant, NewbornMaleCarnitineExome SequencingHomozygoteMethylmalonic AcidMutation, MissenseNeonatal ScreeningPedigreeVitamin B 12Antigens, CD

Stichwörter der Autor:innen

CD320consanguineousmethylmalonic acid (MMA)missense variantnovelpropionylcarnitine (C3)transcobalamin receptor impairment

Substanzen

CarnitineCD320 protein, humanMethylmalonic AcidpropionylcarnitineReceptors, Cell SurfaceVitamin B 12Antigens, CD

Autor:innen und Institutionen

  • Clinical Laboratory Sciences, Applied Medical Science, Taibah University, Medina 42353, Saudi Arabia.
  • Center for Genetics and Inherited Diseases, Taibah University, Medina 42318, Saudi Arabia.
  • Alhada Armed Forces Hospital, Ministry of Defence, Taif 26792, Saudi Arabia.

ORCID-Profile: Faisal Almalki, Haya Alruqi

Förderung

  • Research, Development and Innovation Authority
  • Research, Development and Innovation Authority, Kingdom of Saudi Arabia

Zitieren

APA

Almalki, F., Alsofyany, A. S., Almalki, A. K., Abu Shuaylan, A. O., Alruqi, H., & Althobiti, J. M. (2026). Identification of CD320-Associated Cobalamin Transport Deficiency Through Newborn Screening Caused by Novel Homozygous Candidate Variants. Genes. https://doi.org/10.3390/genes17091108

Vancouver

Almalki F, Alsofyany AS, Almalki AK, Abu Shuaylan AO, Alruqi H, Althobiti JM. Identification of CD320-Associated Cobalamin Transport Deficiency Through Newborn Screening Caused by Novel Homozygous Candidate Variants. Genes. 2026. doi:10.3390/genes17091108

BibTeX
@article{Almalki2026,
  author = {Almalki, Faisal and Alsofyany, Amal Saleh and Almalki, Abdulaziz K and Abu Shuaylan, Ashraf Oudah and Alruqi, Haya and Althobiti, Jwaher Mesleh},
  title = {Identification of CD320-Associated Cobalamin Transport Deficiency Through Newborn Screening Caused by Novel Homozygous Candidate Variants},
  journal = {Genes},
  year = {2026},
  doi = {10.3390/genes17091108}
}
Kostenlos starten →